Author: Green Talk
Website: http://feedproxy.google.com/~r/green-talk/jRYI/~3/BdqyZwmrlK…

Photo by permission of Chloe Delong

The Food and Drug Administration (FDA) recently approved Latisse, which is made by Allergan to treat a condition known as hypotrichosis of the eyelashes, or in plain English, a person who does not have enough or inadequate eyelashes. According to Allergan, lush eyelashes were realized within sixteen weeks of initial treatment. Allergan is also the maker of Botox.

“LATISSE(TM) fulfills a significant and previously unmet need in the medical aesthetic marketplace with a product approved by the FDA that increases the growth of eyelashes, making them longer, thicker and darker,” said Scott Whitcup, M.D., Allergan’s Executive Vice President of Research and Development. “As the global leader in medical aesthetics, LATISSE(TM) exemplifies our continuing commitment to developing innovative treatments that are studied in well-controlled clinical trials, manufactured to pharmaceutical standards, appropriately labeled for use, and available to consumers as…

(Read the rest of this article at the following article source link for the full story)

For more information click the following article source link for the full story:
http://feedproxy.google.com/~r/green-talk/jRYI/~3/BdqyZwmrlK…